Search

Select theme:

Shopping cart

Subtotal
$97.00
View cart Checkout

Saved articles

You have not yet added any article to your bookmarks!

Browse articles
Newsletter image

Subscribe to the Newsletter

Join 10k+ people to get notified about new posts, news and tips.

Do not worry we don't spam!

GDPR Compliance

We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

  • Home
Public Engagement and Clinical Trials: New Models and Disruptive Technologies

Public Engagement and Clinical Trials: New Models and Disruptive Technologies

By Victoria Weisfeld, Forum on Drug Discovery, Development, and Translation & Institute of Medicine Medical 17/02/2012

Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials.

Read More
More Books from Victoria Weisfeld, Forum on Drug Discovery, Development, and Translation & Institute of Medicine
Black Cat Weekly #43 Victoria Weisfeld, John Varley, Daniel Marcus, Robert Lopresti, Isaac Asimov, George O Smith, Murray Leinster, Robert Silverberg, Edwin Balmer & Nicholas Carter
Black Cat Weekly #43
The Future of Home Health Care Victoria Weisfeld
The Future of Home Health Care
Sherlock Holmes Mystery Magazine #28 Marvin Kaye, Gary Lovisi, Victoria Weisfeld, Dan Andriacco, Janice Law, Arthur Conan Doyle & Michael Penncavage
Sherlock Holmes Mystery Magazine #28
Promising and Best Practices in Total Worker Health Victoria Weisfeld
Promising and Best Practices in Total Worker Health
International Regulatory Harmonization Amid Globalization of Drug Development Victoria Weisfeld
International Regulatory Harmonization Amid Globalization of Drug Development
Architect of Courage Victoria Weisfeld
Architect of Courage
Architect of Courage Victoria Weisfeld
Architect of Courage
Public Engagement and Clinical Trials: New Models and Disruptive Technologies Victoria Weisfeld, Forum on Drug Discovery, Development, and Translation & Institute of Medicine
Public Engagement and Clinical Trials: New Models and Disruptive Technologies
Comments